105 related articles for article (PubMed ID: 1904902)
1. Soluble IL-2 receptor as an agent of serum-mediated suppression in human visceral leishmaniasis.
Barral-Netto M; Barral A; Santos SB; Carvalho EM; Badaro R; Rocha H; Reed SG; Johnson WD
J Immunol; 1991 Jul; 147(1):281-4. PubMed ID: 1904902
[TBL] [Abstract][Full Text] [Related]
2. Restoration of IFN-gamma production and lymphocyte proliferation in visceral leishmaniasis.
Carvalho EM; Bacellar O; Brownell C; Regis T; Coffman RL; Reed SG
J Immunol; 1994 Jun; 152(12):5949-56. PubMed ID: 8207220
[TBL] [Abstract][Full Text] [Related]
3. IL-12 enhances Th1-type responses in human Leishmania donovani infections.
Ghalib HW; Whittle JA; Kubin M; Hashim FA; el-Hassan AM; Grabstein KH; Trinchieri G; Reed SG
J Immunol; 1995 May; 154(9):4623-9. PubMed ID: 7722314
[TBL] [Abstract][Full Text] [Related]
4. Elevated plasma levels of interferon (IFN)-gamma, IFN-gamma inducing cytokines, and IFN-gamma inducible CXC chemokines in visceral leishmaniasis.
Hailu A; van der Poll T; Berhe N; Kager PA
Am J Trop Med Hyg; 2004 Nov; 71(5):561-7. PubMed ID: 15569785
[TBL] [Abstract][Full Text] [Related]
5. Interleukin-12 augments a Th1-type immune response manifested as lymphocyte proliferation and interferon gamma production in Leishmania infantum-infected dogs.
Strauss-Ayali D; Baneth G; Shor S; Okano F; Jaffe CL
Int J Parasitol; 2005 Jan; 35(1):63-73. PubMed ID: 15619517
[TBL] [Abstract][Full Text] [Related]
6. Reduction in the number of UCHL-1+ cells and IL-2 production in the peripheral blood of patients with visceral leishmaniasis.
Cillari E; Milano S; Dieli M; Maltese E; Di Rosa S; Mansueto S; Salerno A; Liew FY
J Immunol; 1991 Feb; 146(3):1026-30. PubMed ID: 1824848
[TBL] [Abstract][Full Text] [Related]
7. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
Elg SA; Hill RB; Heldman L; Ramakrishnan S
Gynecol Oncol; 1997 Jul; 66(1):133-7. PubMed ID: 9234933
[TBL] [Abstract][Full Text] [Related]
8. Increased levels of soluble interleukin-4 receptor in the sera of patients with visceral leishmaniasis.
Sang DK; Ouma JH; John CC; Whalen CC; King CL; Mahmoud AA; Heinzel FP
J Infect Dis; 1999 Mar; 179(3):743-6. PubMed ID: 9952391
[TBL] [Abstract][Full Text] [Related]
9. The significance of serum soluble IL-2 receptor as a marker for active visceral leishmaniasis in Sicilian patients.
Vitale G; Reina G; Mansueto S; Malta R; Gambino G; Mocciaro C; D'Agostino R; Dieli M; Cillari E
Clin Exp Immunol; 1992 Nov; 90(2):219-22. PubMed ID: 1424277
[TBL] [Abstract][Full Text] [Related]
10. Regulation by interleukin 2 of interleukin 2 receptors and gamma-interferon synthesis by human thymocytes: augmentation of interleukin 2 receptors by interleukin 2.
Reem GH; Yeh NH
J Immunol; 1985 Feb; 134(2):953-8. PubMed ID: 2981271
[TBL] [Abstract][Full Text] [Related]
11. Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2.
Vilcek J; Henriksen-Destefano D; Siegel D; Klion A; Robb RJ; Le J
J Immunol; 1985 Sep; 135(3):1851-6. PubMed ID: 3926889
[TBL] [Abstract][Full Text] [Related]
12. Elevation of soluble IL-2 receptor and IL-4, and nonelevation of IFN-gamma in sera from patients with allergic asthma.
Hashimoto S; Amemiya E; Tomita Y; Kobatashi T; Arai K; Yamaguchi M; Horie T
Ann Allergy; 1993 Nov; 71(5):455-8. PubMed ID: 8250351
[TBL] [Abstract][Full Text] [Related]
13. Beryllium induces IL-2 and IFN-gamma in berylliosis.
Tinkle SS; Kittle LA; Schumacher BA; Newman LS
J Immunol; 1997 Jan; 158(1):518-26. PubMed ID: 8977230
[TBL] [Abstract][Full Text] [Related]
14. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulating effects in vitro of interleukin-2 and interferon-gamma on human blood and bone marrow mononuclear cells.
Kedar E; Rezai AR; Giorgi JV; Gale RP; Champlin RE; Mitsuyasu RT; Fahey JL
Nat Immun Cell Growth Regul; 1988; 7(1):13-30. PubMed ID: 2896298
[TBL] [Abstract][Full Text] [Related]
16. Sera from patients with the acquired immunodeficiency syndrome inhibit production of interleukin-2 by normal lymphocytes.
Siegel JP; Djeu JY; Stocks NI; Masur H; Gelmann EP; Quinnan GV
J Clin Invest; 1985 Jun; 75(6):1957-64. PubMed ID: 2989337
[TBL] [Abstract][Full Text] [Related]
17. Leishmania donovani: role of CD2 on CD4+ T-cell function in Visceral Leishmaniasis.
Bimal S; Singh SK; Sinha S; Pandey K; Sinha PK; Ranjan A; Bhattacharya SK; Das P
Exp Parasitol; 2008 Feb; 118(2):238-46. PubMed ID: 17904553
[TBL] [Abstract][Full Text] [Related]
18. Immune activation in cervical neoplasia: cross-sectional association between plasma soluble interleukin 2 receptor levels and disease.
Hildesheim A; Schiffman MH; Tsukui T; Swanson CA; Lucci J; Scott DR; Glass AG; Rush BB; Lorincz AT; Corrigan A; Burk RD; Helgesen K; Houghten RA; Sherman ME; Kurman RJ; Berzofsky JA; Kramer TR
Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):807-13. PubMed ID: 9332763
[TBL] [Abstract][Full Text] [Related]
19. The major circulating immunosuppressive activity in American visceral leishmaniasis patients is associated with a high-molecular weight fraction and is not mediated by IgG, IgG immune complexes or lipoproteins.
Soares NM; Ferraz TP; Nascimento EG; Carvalho EM; Pontes-de-Carvalho L
Microb Pathog; 2006 Jun; 40(6):254-60. PubMed ID: 16626930
[TBL] [Abstract][Full Text] [Related]
20. Novel mechanism for Trypanosoma cruzi-induced suppression of human lymphocytes. Inhibition of IL-2 receptor expression.
Beltz LA; Sztein MB; Kierszenbaum F
J Immunol; 1988 Jul; 141(1):289-94. PubMed ID: 3132504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
